{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T17:48:35Z","timestamp":1792259315075,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Vasospasm is a potentially devastating condition that can develop in pediatric patients secondary to traumatic, inflammatory, infectious, and neoplastic etiologies and carries a high risk of morbidity and mortality (Isola et al. 2022, Krishna et al. 2005). Management is often adapted from adult to pediatric care given its relative rarity in children. There is level 3 evidence for the use of intrathecal (IT) calcium channel blocker (nicardipine) administration to treat refractory vasospasm in the adult subarachnoid hemorrhage (SAH) population. Its use has yet to be investigated in children (Krishna et al. 2005). We aim to review the safety profile and efficacy of IT nicardipine for non-traumatic SAH with refractory vasospasm at our institution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We present a single institution retrospective series of pediatric patients treated with IT nicardipine for symptomatic vasospasm refractory to standard therapies including oral nimodipine, hyperdynamic augmentation therapies, and targeted intra-arterial therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Pediatric patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093), ages 16\u201317\u00a0years old, admitted with non-traumatic SAH who developed severe, symptomatic, and refractory vasospasm were included. All patients presented with SAH from ruptured aneurysms. A 5-day course of IT nicardipine was initiated using a protocol adapted from our adult cerebrovascular\/neurocritical care service. Decreases in peak middle cerebral artery velocity (range 61\u2013290\u00a0cm\/s) and Lindegaard ratios (range 0.3\u20134.2) were observed from initiation to completion of treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IT nicardipine for pediatric non-traumatic SAH with vasospasm refractory to standard treatments was used in our small series with no complications and no new ischemic events. Clinical and radiographic effects were encouraging. Further study is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00381-025-06868-4","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T17:12:46Z","timestamp":1749489166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intrathecal nicardipine for symptomatic, refractory vasospasm treatment in pediatric patients: a case series"],"prefix":"10.1007","volume":"41","author":[{"given":"Lucinda","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Plonsker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Dayanara","family":"Villalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"DeCuypere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tord","family":"Alden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Scoville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3294-6637","authenticated-orcid":false,"given":"Sandi","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"3","key":"6868_CR1","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s12028-021-01388-w","volume":"36","author":"C Isola","year":"2022","unstructured":"Isola C, Evain JN, Francony G et al (2022) Cerebral vasospasm in children with subarachnoid hemorrhage: frequency, diagnosis, and therapeutic management. Neurocrit Care 36(3):868\u2013875. https:\/\/doi.org\/10.1007\/s12028-021-01388-w","journal-title":"Neurocrit Care"},{"issue":"5","key":"6868_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00701-005-0481-y","volume":"147","author":"H Krishna","year":"2005","unstructured":"Krishna H, Wani AA, Behari S, Banerji D, Chhabra DK, Jain VK (2005) Intracranial aneurysms in patients 18 years of age or under, are they different from aneurysms in adult population? Acta Neurochir (Wien) 147(5):469\u2013476. https:\/\/doi.org\/10.1007\/s00701-005-0481-y","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"6868_CR3","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00381-013-2336-9","volume":"30","author":"K Garg","year":"2014","unstructured":"Garg K, Singh PK, Sharma BS et al (2014) Pediatric intracranial aneurysms\u2014our experience and review of literature. Childs Nerv Syst 30(5):873\u2013883. https:\/\/doi.org\/10.1007\/s00381-013-2336-9","journal-title":"Childs Nerv Syst"},{"issue":"10","key":"6868_CR4","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.11124\/JBISRIR-2017-003493","volume":"16","author":"D Stuart","year":"2018","unstructured":"Stuart D, Christian R, Uschmann H, Palokas M (2018) Effectiveness of intrathecal nicardipine on cerebral vasospasm in non-traumatic subarachnoid hemorrhage: a systematic review. JBI Evid Synth 16(10):2013. https:\/\/doi.org\/10.11124\/JBISRIR-2017-003493","journal-title":"JBI Evid Synth"},{"key":"6868_CR5","doi-asserted-by":"publisher","unstructured":"Horak VJ, Patel N, Abdelmageed S, Scoville J, LoPresti MA, Lam S (2024) First use of intraventricular nicardipine in a pediatric patient with vasospasm secondary to meningitis: illustrative case. https:\/\/doi.org\/10.3171\/CASE23765","DOI":"10.3171\/CASE23765"},{"issue":"24","key":"6868_CR6","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/ajhp\/zxae240","volume":"81","author":"M Javellana","year":"2024","unstructured":"Javellana M, Asbury WH, Kandiah P et al (2024) Use of dual intraventricular vasodilators for refractory cerebral vasospasm in a pediatric patient with traumatic subarachnoid hemorrhage: a case report. Am J Health Syst Pharm 81(24):1230\u20131236. https:\/\/doi.org\/10.1093\/ajhp\/zxae240","journal-title":"Am J Health Syst Pharm"},{"key":"6868_CR7","doi-asserted-by":"publisher","unstructured":"Ecker A, Riemenschneider PA (1951) Arteriographic demonstration of spasm of the intracranial arteries with special reference to saccular arterial aneurisms. https:\/\/doi.org\/10.3171\/jns.1951.8.6.0660","DOI":"10.3171\/jns.1951.8.6.0660"},{"issue":"1","key":"6868_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3171\/jns.1984.60.1.0037","volume":"60","author":"R Aaslid","year":"1984","unstructured":"Aaslid R, Huber P, Nornes H (1984) Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg 60(1):37\u201341. https:\/\/doi.org\/10.3171\/jns.1984.60.1.0037","journal-title":"J Neurosurg"},{"issue":"1","key":"6868_CR9","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1161\/STROKEAHA.114.006498","volume":"47","author":"RL Macdonald","year":"2016","unstructured":"Macdonald RL (2016) Origins of the concept of vasospasm. Stroke 47(1):e11\u2013e15. https:\/\/doi.org\/10.1161\/STROKEAHA.114.006498","journal-title":"Stroke"},{"issue":"12","key":"6868_CR10","first-page":"1143","volume":"19","author":"A Toyota","year":"1991","unstructured":"Toyota A, Nishizawa Y (1991) Cerebral vasospasm after subarachnoid hemorrhage, and inhibitory effect of nicardipine investigated by means of transcranial Doppler ultrasonography. No Shinkei Geka 19(12):1143\u20131150","journal-title":"No Shinkei Geka"},{"issue":"2","key":"6868_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12028-018-0659-9","volume":"31","author":"S Hafeez","year":"2019","unstructured":"Hafeez S, Grandhi R (2019) Systematic review of intrathecal nicardipine for the treatment of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care 31(2):399\u2013405. https:\/\/doi.org\/10.1007\/s12028-018-0659-9","journal-title":"Neurocrit Care"},{"issue":"1","key":"6868_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF01401450","volume":"131","author":"M Shibuya","year":"1994","unstructured":"Shibuya M, Suzuki Y, Enomoto H, Okada T, Ogura K, Sugita K (1994) Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 131(1):19\u201325. https:\/\/doi.org\/10.1007\/BF01401450","journal-title":"Acta Neurochir (Wien)"},{"key":"6868_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clineuro.2016.02.037","volume":"144","author":"SB Ko","year":"2016","unstructured":"Ko SB, Choi HA, Helbok R et al (2016) Acute effects of intraventricular nicardipine on cerebral hemodynamics: a preliminary finding. Clin Neurol Neurosurg 144:48\u201352. https:\/\/doi.org\/10.1016\/j.clineuro.2016.02.037","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"6868_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1017\/cjn.2015.288","volume":"43","author":"JM Findlay","year":"2016","unstructured":"Findlay JM, Nisar J, Darsaut T (2016) Cerebral vasospasm: a review. Can J Neurol Sci 43(1):15\u201332. https:\/\/doi.org\/10.1017\/cjn.2015.288","journal-title":"Can J Neurol Sci"},{"key":"6868_CR15","doi-asserted-by":"publisher","first-page":"256713","DOI":"10.1155\/2013\/256713","volume":"2013","author":"H Kistka","year":"2013","unstructured":"Kistka H, Dewan MC, Mocco J (2013) Evidence-based cerebral vasospasm surveillance. Neurol Res Int 2013:256713. https:\/\/doi.org\/10.1155\/2013\/256713","journal-title":"Neurol Res Int"},{"key":"6868_CR16","doi-asserted-by":"publisher","unstructured":"Sharma S, Lubrica RJ, Song M, Vandse R, Boling W, Pillai P (2020) The role of transcranial Doppler in cerebral vasospasm: a literature review. In: Martin RD, Boling W, Chen G, Zhang JH, eds. Subarachnoid hemorrhage: neurological care and protection. Springer International Publishing; 201\u2013205. https:\/\/doi.org\/10.1007\/978-3-030-04615-6_32","DOI":"10.1007\/978-3-030-04615-6_32"},{"key":"#cr-split#-6868_CR17.1","doi-asserted-by":"crossref","unstructured":"Ivanidze J, Sanelli PC (2021) Vasospasm - ClinicalKey. In: Neuroimaging clinics of North America. Vol 31. 2nd ed. Elsevier","DOI":"10.1016\/S1052-5149(21)00016-2"},{"key":"#cr-split#-6868_CR17.2","unstructured":"2021:147-155. Accessed January 23, 2025. https:\/\/www-clinicalkey-com.ezproxy.rush.edu\/#!\/content\/playContent\/1-s2.0-S1052514921000046?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1052514921000046%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F"},{"key":"6868_CR18","doi-asserted-by":"publisher","unstructured":"Szuflita NS, Chotai S, Feldman MJ et al (2024) Variations in the management of pediatric cerebral vasospasm. https:\/\/doi.org\/10.3171\/2024.6.PEDS2439","DOI":"10.3171\/2024.6.PEDS2439"},{"issue":"12","key":"6868_CR19","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s00381-017-3573-0","volume":"33","author":"J Skoch","year":"2017","unstructured":"Skoch J, Tahir R, Abruzzo T, Taylor JM, Zuccarello M, Vadivelu S (2017) Predicting symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage with an artificial neural network in a pediatric population. Childs Nerv Syst 33(12):2153\u20132157. https:\/\/doi.org\/10.1007\/s00381-017-3573-0","journal-title":"Childs Nerv Syst"},{"issue":"6","key":"6868_CR20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/adc.63.6.606","volume":"63","author":"H Bode","year":"1988","unstructured":"Bode H, Wais U (1988) Age dependence of flow velocities in basal cerebral arteries. Arch Dis Child 63(6):606\u2013611","journal-title":"Arch Dis Child"},{"issue":"1\u20132","key":"6868_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/BF01405268","volume":"100","author":"KF Lindegaard","year":"1989","unstructured":"Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P (1989) Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien) 100(1\u20132):12\u201324. https:\/\/doi.org\/10.1007\/BF01405268","journal-title":"Acta Neurochir (Wien)"},{"issue":"6","key":"6868_CR22","first-page":"1237","volume":"44","author":"YY Vora","year":"1999","unstructured":"Vora YY, Suarez-Almazor M, Steinke DE, Martin ML, Findlay JM (1999) Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 44(6):1237\u20131247","journal-title":"Neurosurgery"},{"key":"6868_CR23","unstructured":"Cattin F, Bonneville J (1999) Doppler transcr\u00e2nien et vasospasme c\u00e9r\u00e9bral. J Neuroradiol (1 Suppl):S22\u20137"},{"key":"6868_CR24","doi-asserted-by":"publisher","unstructured":"Moftakhar P, Cooke DL, Fullerton HJ, et al (2015) Extent of collateralization predicting symptomatic cerebral vasospasm among pediatric patients: correlations among angiography, transcranial Doppler ultrasonography, and clinical findings. https:\/\/doi.org\/10.3171\/2014.9.PEDS14313","DOI":"10.3171\/2014.9.PEDS14313"},{"issue":"2","key":"6868_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-0040-1715128","volume":"10","author":"NF O\u2019Brien","year":"2021","unstructured":"O\u2019Brien NF, Reuter-Rice K, Wainwright MS et al (2021) Practice recommendations for transcranial Doppler ultrasonography in critically ill children in the pediatric intensive care unit: a multidisciplinary expert consensus statement. J Pediatr Intensive Care 10(2):133\u2013142. https:\/\/doi.org\/10.1055\/s-0040-1715128","journal-title":"J Pediatr Intensive Care"},{"issue":"15","key":"6868_CR26","doi-asserted-by":"publisher","first-page":"e021845","DOI":"10.1161\/JAHA.121.021845","volume":"10","author":"WS Dodd","year":"2021","unstructured":"Dodd WS, Laurent D, Dumont AS et al (2021) Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: a review. J Am Heart Assoc 10(15):e021845. https:\/\/doi.org\/10.1161\/JAHA.121.021845","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"6868_CR27","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/cc5958","volume":"11","author":"SG Keyrouz","year":"2007","unstructured":"Keyrouz SG, Diringer MN (2007) Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care 11(4):220. https:\/\/doi.org\/10.1186\/cc5958","journal-title":"Crit Care"},{"issue":"7","key":"6868_CR28","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1161\/STR.0000000000000436","volume":"54","author":"BL Hoh","year":"2023","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S et al (2023) 2023 Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke 54(7):e314\u2013e370. https:\/\/doi.org\/10.1161\/STR.0000000000000436","journal-title":"Stroke"},{"issue":"8","key":"6868_CR29","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1007\/s00330-016-4702-y","volume":"27","author":"G Boulouis","year":"2017","unstructured":"Boulouis G, Labeyrie MA, Raymond J et al (2017) Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis. Eur Radiol 27(8):3333\u20133342. https:\/\/doi.org\/10.1007\/s00330-016-4702-y","journal-title":"Eur Radiol"},{"key":"6868_CR30","doi-asserted-by":"publisher","unstructured":"Grossen AA, Ernst GL, Bauer AM (2022) Update on intrathecal management of cerebral vasospasm: a systematic review and meta-analysis. https:\/\/doi.org\/10.3171\/2021.12.FOCUS21629","DOI":"10.3171\/2021.12.FOCUS21629"},{"key":"6868_CR31","doi-asserted-by":"publisher","first-page":"101045","DOI":"10.1016\/j.inat.2020.101045","volume":"24","author":"JM Parish","year":"2021","unstructured":"Parish JM, Ziechmann R, Guley NM et al (2021) Safety and efficacy of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage induced vasospasm. Interdiscip Neurosurg 24:101045. https:\/\/doi.org\/10.1016\/j.inat.2020.101045","journal-title":"Interdiscip Neurosurg"},{"issue":"3","key":"6868_CR32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s12028-011-9537-4","volume":"15","author":"N Rosenberg","year":"2011","unstructured":"Rosenberg N, Lazzaro MA, Lopes DK, Prabhakaran S (2011) High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage. Neurocrit Care 15(3):400\u2013404. https:\/\/doi.org\/10.1007\/s12028-011-9537-4","journal-title":"Neurocrit Care"},{"issue":"3","key":"6868_CR33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12028-011-9659-8","volume":"16","author":"N Lu","year":"2012","unstructured":"Lu N, Jackson D, Luke S, Festic E, Hanel RA, Freeman WD (2012) Intraventricular nicardipine for aneurysmal subarachnoid hemorrhage related vasospasm: assessment of 90 days outcome. Neurocrit Care 16(3):368\u2013375. https:\/\/doi.org\/10.1007\/s12028-011-9659-8","journal-title":"Neurocrit Care"},{"issue":"2","key":"6868_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12028-009-9307-8","volume":"12","author":"A Webb","year":"2010","unstructured":"Webb A, Kolenda J, Martin K, Wright W, Samuels O (2010) The effect of intraventricular administration of nicardipine on mean cerebral blood flow velocity measured by transcranial Doppler in the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurocrit Care 12(2):159\u2013164. https:\/\/doi.org\/10.1007\/s12028-009-9307-8","journal-title":"Neurocrit Care"},{"issue":"4","key":"6868_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s101430100152","volume":"24","author":"M Suzuki","year":"2001","unstructured":"Suzuki M, Doi M, Otawara Y, Ogasawara K, Ogawa A (2001) Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage. Neurosurg Rev 24(4):180\u2013184. https:\/\/doi.org\/10.1007\/s101430100152","journal-title":"Neurosurg Rev"},{"key":"6868_CR36","doi-asserted-by":"publisher","unstructured":"Sadan O, Waddel H, Moore R, et al (2021) Does intrathecal nicardipine for cerebral vasospasm following subarachnoid hemorrhage correlate with reduced delayed cerebral ischemia? A retrospective propensity score\u2013based analysis. https:\/\/doi.org\/10.3171\/2020.12.JNS203673","DOI":"10.3171\/2020.12.JNS203673"},{"issue":"10069","key":"6868_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(16)32410-2","volume":"389","author":"DF Hanley","year":"2017","unstructured":"Hanley DF, Lane K, McBee N et al (2017) Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. The Lancet 389(10069):603\u2013611. https:\/\/doi.org\/10.1016\/S0140-6736(16)32410-2","journal-title":"The Lancet"},{"key":"6868_CR38","doi-asserted-by":"publisher","unstructured":"Won YD, Cheong JW, Park YK, Yoon BH, Kim JH, Kang HI (2024) Shunt-dependent hydrocephalus and shunt failure rate in patients with aneurysmal subarachnoid hemorrhage in Korea. https:\/\/doi.org\/10.3171\/2024.2.JNS232933","DOI":"10.3171\/2024.2.JNS232933"},{"issue":"3","key":"6868_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/neuros\/nyx393","volume":"83","author":"GM Paisan","year":"2018","unstructured":"Paisan GM, Ding D, Starke RM, Crowley RW, Liu KC (2018) Shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage: predictors and long-term functional outcomes. Neurosurgery 83(3):393\u2013402. https:\/\/doi.org\/10.1093\/neuros\/nyx393","journal-title":"Neurosurgery"},{"issue":"2","key":"6868_CR40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/SMJ.0b013e31818f8ba4","volume":"102","author":"A Ehtisham","year":"2009","unstructured":"Ehtisham A, Taylor S, Bayless L, Samuels OB, Klein MW, Janzen JM (2009) Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm. South Med J 102(2):150\u2013153. https:\/\/doi.org\/10.1097\/SMJ.0b013e31818f8ba4","journal-title":"South Med J"},{"issue":"1","key":"6868_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12028-023-01847-6","volume":"40","author":"MM Caylor","year":"2024","unstructured":"Caylor MM, Macdonald RL (2024) Pharmacological prevention of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Neurocrit Care 40(1):159\u2013169. https:\/\/doi.org\/10.1007\/s12028-023-01847-6","journal-title":"Neurocrit Care"},{"issue":"1","key":"6868_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12028-023-01738-w","volume":"39","author":"S Deem","year":"2023","unstructured":"Deem S, Diringer M, Livesay S, Treggiari MM (2023) Hemodynamic management in the prevention and treatment of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neurocrit Care 39(1):81\u201390. https:\/\/doi.org\/10.1007\/s12028-023-01738-w","journal-title":"Neurocrit Care"},{"key":"6868_CR43","doi-asserted-by":"publisher","first-page":"059","DOI":"10.1055\/s-0040-1710320","volume":"42","author":"JA Russell","year":"2020","unstructured":"Russell JA, Gordon AC, Williams MD, Boyd JH, Walley KR, Kissoon N (2020) Vasopressor therapy in the intensive care unit. Semin Respir Crit Care Med 42:059\u2013077. https:\/\/doi.org\/10.1055\/s-0040-1710320","journal-title":"Semin Respir Crit Care Med"},{"key":"6868_CR44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jor.2020.10.012","volume":"22","author":"M Livesey","year":"2020","unstructured":"Livesey M, Jauregui JJ, Hamaker MC, Pensy RA, Langhammer CG, Eglseder WA (2020) Management of vasopressor induced ischemia. J Orthop 22:497\u2013502. https:\/\/doi.org\/10.1016\/j.jor.2020.10.012","journal-title":"J Orthop"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-025-06868-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-025-06868-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-025-06868-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:18:57Z","timestamp":1770815937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-025-06868-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["6868"],"URL":"https:\/\/doi.org\/10.1007\/s00381-025-06868-4","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board (IRB) approval was obtained, and this case series study was deemed exempt prior to initiation (IRB #: 2024\u20137238). HIPAA authorization was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from parents prior to treatment. Within this written informed consent, the parents acknowledged that the hospital may use the patient\u2019s deidentified data for research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent for publication was not obtained as all patient information was anonymized, and the submission does not include images that may identify the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}